PharmacyCodes



Furadantin Retard en es it fr

Furadantin Retard Brand names, Furadantin Retard Analogs

Furadantin Retard Brand Names Mixture

  • No information avaliable

Furadantin Retard Chemical_Formula

C8H6N4O5

Furadantin Retard RX_link

http://www.rxlist.com/cgi/generic/nitro25m.htm

Furadantin Retard fda sheet

Furadantin Retard msds (material safety sheet)

Furadantin_Retard MSDS

Furadantin Retard Synthesis Reference

No information avaliable

Furadantin Retard Molecular Weight

238.157 g/mol

Furadantin Retard Melting Point

263 oC

Furadantin Retard H2O Solubility

79.5 mg/L

Furadantin Retard State

Solid

Furadantin Retard LogP

-0.04

Furadantin Retard Dosage Forms

Tablet

Furadantin Retard Indication

For the treatment of infection of the urinary tract

Furadantin Retard Pharmacology

Nitrofurantoin, a nitrofuran antibacterial agent, is available in microcrystalline and macrocrystalline form to treat urinary tract infections caused by many gram-negative and some gram-positive bacteria.

Furadantin Retard Absorption

No information avaliable

Furadantin Retard side effects and Toxicity

No information avaliable

Furadantin Retard Patient Information

Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

Furadantin Retard Organisms Affected

Gram negative and some gram positive bacteria